Drugs / B-CLL Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01604031 | Feb 2013 → Apr 2015 | B-cell chronic lymphocytic leukemia | Baylor College of Medicine | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | B-CLL Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01604031 ↗ |
| Modality | Cell therapy | “IL-2 secreting B-cells” NCT01604031 ↗ |
| Route | Subcutaneous | “The vaccine will be injected under the skin (also called subcutaneously).” NCT01604031 ↗ |